# Brainsway Ltd.: overview BWAY · Nasdaq · CIK 1505065 · [Healthcare](/sectors/healthcare.md) Pages: [Overview](/companies/bway.md) · [Financials](/companies/bway/financials.md) · [Filings](/companies/bway/filings.md) · [Insiders](/companies/bway/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [22.1](/filings/0001171843-23-001915.md) | [29.7](/filings/0001171843-24-001696.md) | [27.2](/filings/0001171843-25-002347.md) | [31.8](/filings/0001171843-25-002347.md) | [41.0](/filings/0001171843-25-002347.md) | | Gross margin | % | [77.1%](/filings/0001171843-23-001915.md) | [77.7%](/filings/0001171843-24-001696.md) | [73.8%](/filings/0001171843-25-002347.md) | [73.9%](/filings/0001171843-25-002347.md) | [74.6%](/filings/0001171843-25-002347.md) | | Operating margin | % | [(21.9%)](/filings/0001171843-23-001915.md) | [(16.9%)](/filings/0001171843-24-001696.md) | [(46.7%)](/filings/0001171843-25-002347.md) | [(15.6%)](/filings/0001171843-25-002347.md) | [3.4%](/filings/0001171843-25-002347.md) | | Net margin | % | [(24.4%)](/filings/0001171843-23-001915.md) | [(21.8%)](/filings/0001171843-24-001696.md) | [(49.1%)](/filings/0001171843-25-002347.md) | [(13.2%)](/filings/0001171843-25-002347.md) | [7.1%](/filings/0001171843-25-002347.md) | | Diluted EPS | $ per share | not reported | [(0.21)](/filings/0001171843-24-001696.md) | [(0.40)](/filings/0001171843-25-002347.md) | [(0.13)](/filings/0001171843-25-002347.md) | [0.05](/filings/0001171843-25-002347.md) | | Free cash flow | $m | [(3.9)](/filings/0001171843-23-001915.md) | [(1.4)](/filings/0001171843-24-001696.md) | not reported | not reported | not reported | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Gross profit: ifrs-full:GrossProfit; Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bway/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Valor Management LLC](/funds/1846237.md) | 2026-06-30 | $82.4m | 5,314,950 | | Unchanged | | [MASTERS CAPITAL MANAGEMENT LLC](/funds/1104186.md) | 2026-06-30 | $23.3m | 1,500,000 | | Reduced −150,000 | | [ESSEX INVESTMENT MANAGEMENT CO LLC](/funds/201772.md) | 2026-06-30 | $9.2m | 592,606 | | Reduced −25,947 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $7.4m | 475,920 | | Reduced −42,500 | | [Cresset Asset Management, LLC](/funds/1761013.md) | 2026-06-30 | $4.9m | 314,924 | | Unchanged | | [Y.D. More Investments Ltd](/funds/1870364.md) | 2026-06-30 | $3.7m | 237,433 | | Reduced −34,571 | | [Legato Capital Management LLC](/funds/1442641.md) | 2026-06-30 | $3.1m | 197,635 | | Added +5,485 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $2.9m | 188,968 | | Added +84,574 | | [EAGLE GLOBAL ADVISORS LLC](/funds/1130787.md) | 2026-06-30 | $2.8m | 182,606 | | Added +10,000 | | [ARK Investment Management LLC](/funds/1697748.md) | 2026-06-30 | $2.2m | 142,500 | | Reduced −51,186 | ## Recent filings [All 280 filings](/companies/bway/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 07:30 ET | [6-K](/filings/0001171843-26-006807.md) | Report of a foreign private issuer, period 2026-10-26 | 0001171843-26-006807 | | 2026-10-21 | 16:01 ET | [6-K](/filings/0001171843-26-006741.md) | Report of a foreign private issuer, period 2026-11-25 | 0001171843-26-006741 | | 2026-10-19 | 12:00 ET | [6-K](/filings/0001171843-26-006686.md) | Report of a foreign private issuer, period 2026-10-19 | 0001171843-26-006686 | | 2026-10-13 | 07:30 ET | [6-K](/filings/0001171843-26-006592.md) | Report of a foreign private issuer, period 2026-10-13 | 0001171843-26-006592 | | 2026-09-29 | 16:01 ET | [6-K](/filings/0001171843-26-006290.md) | Report of a foreign private issuer, period 2026-06-30 | 0001171843-26-006290 | | 2026-09-08 | 07:30 ET | [6-K](/filings/0001171843-26-005912.md) | Report of a foreign private issuer, period 2026-09-08 | 0001171843-26-005912 | | 2026-08-27 | 07:30 ET | [6-K](/filings/0001171843-26-005759.md) | Report of a foreign private issuer, period 2026-08-27 | 0001171843-26-005759 | | 2026-08-12 | 16:01 ET | [6-K](/filings/0001171843-26-005454.md) | Report of a foreign private issuer, period 2026-08-12 | 0001171843-26-005454 | | 2026-08-12 | 07:30 ET | [6-K](/filings/0001171843-26-005440.md) | Report of a foreign private issuer, period 2026-08-12 | 0001171843-26-005440 | | 2026-07-20 | 07:30 ET | [6-K](/filings/0001171843-26-004757.md) | Report of a foreign private issuer, period 2026-07-20 | 0001171843-26-004757 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001171843-26-002568.md), filed Apr 20, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1505065 - Tickers: BWAY, BRSYF - Exchange: Nasdaq - SIC code: 3841 Surgical & Medical Instruments & Apparatus - State of incorporation: L3 - Filer category: Accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:02 ET. No prices; not investment advice.